1 min read.Updated: 15 Aug 2022, 11:40 AM ISTLivemint
The multibagger pharma stock is down about 20% in 2022 (YTD) so far
Listen to this article
Pharmaceuticals company Divis Laboratories on Friday reported a 26% rise in its consolidated net profit at ₹702 crore as compared to ₹557 crore in the same quarter last year. Meanwhile, its revenue from operations rose about 15% to ₹2,254 crore from ₹1,960.6 crore year-on-year (YoY).
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.